Klarquist Sparkman, LLP
Synergistic combination of IL-4, interferon gamma, and interferon alpha in treating ovarian cancer
Methods and compositions are disclosed for treating a subject with a cancer. The compositions can include a chimeric molecule comprising an agent that specifically binds the interleukin 4 receptor (IL-4R) and a toxic moiety, an interferon alpha (IFNα), and an interferon gamma (IFNγ). In some non-liming embodiments, the compositions can also include monocytes. The methods disclosed herein include administering a therapeutically effective amount of the compositions taught herein to a subject with cancer, thereby treating the cancer in the subject, wherein cells in the cancer express IL-4R. In some non-liming embodiments, the methods can also include administering monocytes.
The United States of America, as represented by the Secretary, Department of Health and Human Services
A A A C A A C A C A C C A
A61K A61K A61P C07K A61K A61K C07K A61K C07K A61K C07K C07K A61K
additional inventional inventional additional inventional inventional inventional inventional inventional inventional additional additional inventional
Syed R. Raj K. Kathryn C. Daniel S.
Husain Puri Zoon Green